China Merchants Fund Leads $25M Round In Gene-Editing Start-Up Qihan Biotech

Qihan Biotech, a Hangzhou-based biotech startup focused on organ transplantation, announced on Monday that it has raised US$25.5 million in a series A+ funding round.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

LEAVE A REPLY